Heterogeneous data is essential for personalized medicine and precision oncology. By integrating multiple data types, researchers and clinicians can gain a deeper understanding of cancer biology, identify biomarkers for early detection, and develop targeted therapies. This approach helps in tailoring treatments to individual patients, improving outcomes and minimizing side effects.
